Mårten Wigstøl
Chairman at Cimon Medical AS
Mårten Wigstøl active positions
Companies | Position | Start | End |
---|---|---|---|
Magnetic Biosolutions AB
Magnetic Biosolutions AB Medical SpecialtiesHealth Technology Magnetic Biosolutions AB develops medical instruments and software. The company specializes in the development of instruments, software, and protocols for sample preparation using magnetic bead technology. It was founded in 2000 and is headuqartered in Stockholm, Sweden. | Director/Board Member | - | - |
Barracuda Invest AS | Director/Board Member | - | - |
Cimon Medical AS
Cimon Medical AS Electronic Equipment/InstrumentsElectronic Technology Cimon Medical AS develops and manufactures applications for continuous monitoring blood flow. The company is based in Trondheim, Norway. The Norwegian company was founded in 2019 by Tormod Thomsen, Siri Ann Nyrnes. Tormod Thomsen has been the CEO since 2019. | Chairman | - | - |
Defibrio AS
Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Director/Board Member | - | - |
Career history of Mårten Wigstøl
Former positions of Mårten Wigstøl
Companies | Position | Start | End |
---|---|---|---|
NORDA ASA | Investor Relations Contact | 2011-06-26 | - |
Public Communications Contact | 2011-08-23 | - | |
President | 2010-06-17 | - | |
GenoVision AS
GenoVision AS Medical SpecialtiesHealth Technology GenoVision AS develops reagents and solutions for certain nucleic acid diagnostic markets. It has developed products and protocols for the direct isolation of DNA and RNA from a variety of sample sources such as dried blood, leucocytes, serum, buccal cells, cultured cells, biopsy samples, paraffin embedded tissue sections, animal tissue and yeast cells. GenoVision was formed in 1998 and is headquartered in Oslo, Norway | Founder | 2011-06-26 | - |
President | - | - |
Training of Mårten Wigstøl
Henley Business School Ltd. | Masters Business Admin |
University of Laurentian | Undergraduate Degree |
Statistics
International
Norway | 6 |
South Africa | 2 |
Canada | 2 |
Operational
Director/Board Member | 3 |
President | 2 |
Founder | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NORDA ASA | Commercial Services |
Private companies | 5 |
---|---|
GenoVision AS
GenoVision AS Medical SpecialtiesHealth Technology GenoVision AS develops reagents and solutions for certain nucleic acid diagnostic markets. It has developed products and protocols for the direct isolation of DNA and RNA from a variety of sample sources such as dried blood, leucocytes, serum, buccal cells, cultured cells, biopsy samples, paraffin embedded tissue sections, animal tissue and yeast cells. GenoVision was formed in 1998 and is headquartered in Oslo, Norway | Health Technology |
Magnetic Biosolutions AB
Magnetic Biosolutions AB Medical SpecialtiesHealth Technology Magnetic Biosolutions AB develops medical instruments and software. The company specializes in the development of instruments, software, and protocols for sample preparation using magnetic bead technology. It was founded in 2000 and is headuqartered in Stockholm, Sweden. | Health Technology |
Barracuda Invest AS | |
Cimon Medical AS
Cimon Medical AS Electronic Equipment/InstrumentsElectronic Technology Cimon Medical AS develops and manufactures applications for continuous monitoring blood flow. The company is based in Trondheim, Norway. The Norwegian company was founded in 2019 by Tormod Thomsen, Siri Ann Nyrnes. Tormod Thomsen has been the CEO since 2019. | Electronic Technology |
Defibrio AS
Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Health Technology |
- Stock Market
- Insiders
- Mårten Wigstøl
- Experience